| Margarita Stepanyan, | |
|
125 N Central Ave, Glendale, CA 91203-2502 | |
| (818) 637-2758 | |
| Not Available |
| Full Name | Margarita Stepanyan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 125 N Central Ave, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902512726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH87027 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margarita Stepanyan, 2020 Lyans Dr, La Canada, CA 91011-1537 Ph: () - | Margarita Stepanyan, 125 N Central Ave, Glendale, CA 91203-2502 Ph: (818) 637-2758 |
News Archive
Food scientists at the University of British Columbia have been able to pinpoint more of the complex chemistry behind coffee's much touted antioxidant benefits, tracing valuable compounds to the roasting process.
From 1999 to 2007, there were 185,950 emergency department (ED) visits in the U.S. for firearm injuries in children aged 0 to 19 years. A new abstract presented Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston, provided an overview of these injuries, including a variety of risk factors including age, race, hospital location, and insurance type.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
Women who have their labor induced or are given medication to stimulate contractions are at greater risk of developing chorioamnionitis
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.
› Verified 9 days ago
Rosemary Kahale, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Central Ave, Glendale, CA 91203 Phone: 818-637-2758 | |
Annie Ahhyun Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 San Fernando Rd, Glendale, CA 91204 Phone: 818-549-2270 | |
Dr. Linda Kalamkeryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Stocker St, 105, Glendale, CA 91202 Phone: 818-433-8379 | |
Dr. Jane Kyun Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Anna Arutunyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Broadway, Glendale, CA 91205 Phone: 818-547-0170 | |
Dr. Monica Natalia Macias, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Terrace, Glendale, CA 91206 Phone: 818-409-8140 | |
Arash Akmal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3452 Country Club Dr, Glendale, CA 91208 Phone: 310-463-7326 |